Last Updated: 31-07-2025 | Format: PDF | Report ID:20444 | Author: Sophia
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $940 Million |
| What is the projected market size by 2035? | $2,080 Million |
| What is the market CAGR from 2025 to 2035? | 8.3% |
| Which region dominates the market? | US (74%) |
| Which product/service type dominates the market? | Fluorescence-Based (38%) |
| Which application leads the market? | Research (33%) |
| Who are the major buyers? | Academic/Research (43%), Pharma/Biotech (31%) |
| What are the key market growth drivers? | Rising demand for cell-based therapies and precision medicine is significantly boosting adoption of advanced cell sorting technologies; Rapid advancements in microfluidics and automation have dramatically improved sorting speed and accuracy |
| What are the major market challenges? | High capital requirements and technical complexity limit widespread adoption in small and mid-sized labs; Ensuring reproducibility and accuracy when processing heterogeneous sample types remains a challenge |
| What is the forecast period? |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| 2026–2035 |
| Who are the key market players? | BD Biosciences, Beckman Coulter, Sony Biotechnology, Miltenyi Biotec, Bio-Rad Laboratories, Thermo Fisher Scientific, Union Biometrica, Sysmex Partec, On-Chip Biotechnologies, pluriSelect, NanoCellect Biomedical, Cytonome/St, Luminex Corporation, Propel Labs |
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Stem Cell Therapy Market Market: by Type (Allogeneic, Autologous), Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), Distribution Channels (Hospitals, Clinics, Academic & Research Institutes, Contract Research Organizations, Direct Sales, Online Channels), Technology (Stem Cell Acquisition, Stem Cell Preservation, Expansion, Sub-culture, Cryopreservation, Other Technologies), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Circular Plastics Market: by Type (Recycled Plastics, Bioplastics, Reusable Plastics, Compostable Plastics, High-Performance Plastics, Others), Application (Packaging, Automotive, Construction, Electronics, Consumer Goods, Others), Distribution Channels (Online, Offline, Direct Sales, Distributors, Retailers, Others), Technology (Mechanical Recycling, Chemical Recycling, Advanced Sorting, Pyrolysis, Biotechnological Methods, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Cell & Gene Therapy Manufacturing Services Market: by Type (Allogeneic, Autologous, Viral Vector, Non-viral Vector, Plasmid DNA, Others), Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, Others), Distribution Channels (Direct Tenders, Third-Party Distributors, Online Platforms, Others), Technology (Gene Editing, Cell Expansion, Viral Vector Production, Cryopreservation, Automation, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025